Literature DB >> 990249

Equilibrium binding of thrombin to platelets.

B M Martin, W W Wasiewski, J W Fenton, T C Detwiler.   

Abstract

Binding of human [125I]thrombin to washed human platelets was studied in order to analyze the nonenzymic aspects of the thrombin stimulation of platelets. Highly purified alpha-thrombin that was iodinated with lactoperoxidase retained full clotting and esterase activities and full activity toward platelets, was not distinguished from native thrombin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or gel chromatography, and bound to platelets the same as unlabeled thrombin. Bound and free [125I]thrombin were measured after rapid separation of platelets from the suspending medium by centrifugation through oil. Maximum binding was within 15 s, the shortest time measured. At concentrations of thrombin sufficient to cause less than maximal platelet stimulation, 90% of the total thrombin was free in the suspending solutions. Equilibrium binding was established, with both free thrombin and free platelets retaining activity, and with rapid reequilibration after dilution or addition of unlabeled thrombin. The equilibrium was complex, with the apparent number of binding sites and dissociation constants dependent on thrombin concentration. Analysis of bound thrombin as a function of thrombin concentration by double-reciprocal and Scatchard plots indicated 300-400 high affinity sites (Kdiss = 1.8-2 nM); these correlate with thrombin stimulation of Ca2+ secretion, which shows half maximal effect at 1.5 nM thrombin and maximal effect with 500-600 thrombins bound per platelet.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990249     DOI: 10.1021/bi00667a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Thrombin generation and secretion of platelet Factor 4 during blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Reactivity of mouse antibodies against bromelain-treated mouse erythrocytes with thrombin-treated mouse platelets.

Authors:  S Kawaguchi
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

3.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.

Authors:  K A Hajjar; R L Nachman
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture.

Authors:  J B Baker; G S Barsh; D H Carney; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.

Authors:  M W Mosesson; K R Siebenlist; I Hernandez; K N Lee; V J Christiansen; P A McKee
Journal:  J Thromb Haemost       Date:  2008-06-16       Impact factor: 5.824

6.  Thrombin-induced platelet secretion. Further evidence for a specific pathway.

Authors:  M A Shuman; M Botney; J W Fenton
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

7.  Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets.

Authors:  H Holmsen; C A Dangelmaier; S Rongved
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

8.  Binding and internalization of thrombin by normal and transformed chick cells.

Authors:  B R Zetter; L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Reduced thrombin binding and aggregation in Bernard-Soulier platelets.

Authors:  G A Jamieson; T Okumura
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

10.  The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.

Authors:  J O Shaw; P M Henson
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.